Oncological and functional outcomes for transoral robotic surgery versus radiotherapy in T1-2 N0-1 p16+ oropharyngeal carcinoma.

IF 0.8 4区 医学 Q3 OTORHINOLARYNGOLOGY
Chang Woo Lee, Wei Jia, Roanna Norman, Alex Dando, Susan Swain, Francesca Hilder, Maxine Flubacher, Joseph Davies, Oliver Donnelly, Jon Bird, Neil De Zoysa, Emma King
{"title":"Oncological and functional outcomes for transoral robotic surgery versus radiotherapy in T1-2 N0-1 p16+ oropharyngeal carcinoma.","authors":"Chang Woo Lee, Wei Jia, Roanna Norman, Alex Dando, Susan Swain, Francesca Hilder, Maxine Flubacher, Joseph Davies, Oliver Donnelly, Jon Bird, Neil De Zoysa, Emma King","doi":"10.1017/S0022215125000350","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Oncological and functional outcomes for T1-2 N0-1 (TNMv8) p16-positive oropharyngeal squamous cell carcinoma patients were analysed according to treatment: either transoral robotic surgery (TORS) (Surgery group - TORS and neck dissection ± adjuvant radiotherapy/chemoradiotherapy) or primary radiotherapy/chemoradiotherapy (Oncology group).</p><p><strong>Methods: </strong>Single-centre retrospective observational study.</p><p><strong>Results: </strong>The two-year disease-free survival rate was 88 per cent for the Oncology group (n = 42) and 95 per cent for the Surgery group (n = 44). The two-year overall survival rate was 98 per cent for the Oncology group and 100 per cent for the Surgery group. The functional swallowing outcome at two years post-treatment was similar in both groups. Subgroup analysis showed patients treated with surgery-only with no adjuvant treatment had the best functional outcome whilst patients treated with surgery and post-operative chemoradiotherapy had the worst functional outcome.</p><p><strong>Conclusion: </strong>The overall oncological and functional outcomes at two years were similar in both groups. Patients treated with surgery-only had the best functional outcome without compromised oncological outcome.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"730-737"},"PeriodicalIF":0.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Laryngology and Otology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S0022215125000350","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Oncological and functional outcomes for T1-2 N0-1 (TNMv8) p16-positive oropharyngeal squamous cell carcinoma patients were analysed according to treatment: either transoral robotic surgery (TORS) (Surgery group - TORS and neck dissection ± adjuvant radiotherapy/chemoradiotherapy) or primary radiotherapy/chemoradiotherapy (Oncology group).

Methods: Single-centre retrospective observational study.

Results: The two-year disease-free survival rate was 88 per cent for the Oncology group (n = 42) and 95 per cent for the Surgery group (n = 44). The two-year overall survival rate was 98 per cent for the Oncology group and 100 per cent for the Surgery group. The functional swallowing outcome at two years post-treatment was similar in both groups. Subgroup analysis showed patients treated with surgery-only with no adjuvant treatment had the best functional outcome whilst patients treated with surgery and post-operative chemoradiotherapy had the worst functional outcome.

Conclusion: The overall oncological and functional outcomes at two years were similar in both groups. Patients treated with surgery-only had the best functional outcome without compromised oncological outcome.

经口机器人手术与放疗治疗T1-2 N0-1 p16+口咽癌的肿瘤学和功能疗效比较
目的:分析T1-2 N0-1 (TNMv8) p16阳性口咽鳞癌患者的肿瘤和功能结局,根据治疗方法进行分析:经口机器人手术(TORS)(手术组- TORS +颈部清扫±辅助放疗/放化疗)或原发性放疗/放化疗(肿瘤组)。方法:单中心回顾性观察研究。结果:肿瘤组(n = 42)两年无病生存率为88%,手术组(n = 44)两年无病生存率为95%。肿瘤组的两年总生存率为98%,手术组为100%。两组治疗后2年的功能性吞咽结果相似。亚组分析显示,仅接受手术而不进行辅助治疗的患者功能预后最好,而接受手术和术后放化疗的患者功能预后最差。结论:两组患者两年后的总体肿瘤和功能结果相似。仅接受手术治疗的患者具有最佳的功能预后,而不影响肿瘤预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Laryngology and Otology
Journal of Laryngology and Otology 医学-耳鼻喉科学
CiteScore
3.20
自引率
11.80%
发文量
593
审稿时长
3-6 weeks
期刊介绍: The Journal of Laryngology & Otology (JLO) is a leading, monthly journal containing original scientific articles and clinical records in otology, rhinology, laryngology and related specialties. Founded in 1887, JLO is absorbing reading for ENT specialists and trainees. The journal has an international outlook with contributions from around the world, relevant to all specialists in this area regardless of the country in which they practise. JLO contains main articles (original, review and historical), case reports and short reports as well as radiology, pathology or oncology in focus, a selection of abstracts, book reviews, letters to the editor, general notes and calendar, operative surgery techniques, and occasional supplements. It is fully illustrated and has become a definitive reference source in this fast-moving subject area. Published monthly an annual subscription is excellent value for money. Included in the subscription is access to the JLO interactive web site with searchable abstract database of the journal archive back to 1887.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信